ID | CAS | Name | Synonyms | Molecular Formula | Category |
---|---|---|---|---|---|
1 | 1553977-17-5 | Ibrutinib-d5 | Ibrutinib D5 Ibrutinib-d5 [2H5]-Ibrutinib | ||
2 | 936563-97-2 | (S)-Ibrutinib | (S)-Ibrutinib (S)-Ibrutinib-d5 Ibrutinib (S)-Isomer (S)-1-(3-(4-amino-3-(4-phenoxyphenyl) 1-[(3S)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one 2-Propen-1-one, 1-[(3S)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]- | ||
3 | 936563-87-0 | PCI-32765 (Racemate) | Ibrutinib Racemate PCI-32765 (Racemate) PCI-32765 (RaceMate) IBRUTINIB RACEMATE (PCI-32765 RACEMATE) 1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one 2-Propen-1-one, 1-[3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]- 1-(3-(4-Amino-3-(4-phenyloxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one | ||
4 | 865759-10-0 | Alogliptin Related Compound 26 | Alogliptin-11 Alogliptin Impurity 36 Alogliptin Related Compound 26 (R)-2,2'-((6-(3-aminopiperidin-1-yl)-2,4-ioxopyrimidine-1,3(2H,4H)-diyl)bis(methylene))dibenzonitrile (R)-2,2'-((6-(3-aminopiperidin-1-yl)-2,4-dioxopyrimidine-1,3(2H,4H)-diyl)bis(methylene))dibenzonitrile 2,2'-[[6-[(3R)-3-Amino-1-piperidinyl]-2,4-dioxo-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[benzonitrile Benzonitrile, 2,2'-[[6-[(3R)-3-amino-1-piperidinyl]-2,4-dioxo-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis- | ||
5 | N-(2-METHOXYPHENYL)-4-(8-PYRIMIDIN-5-YLQUINOLIN-2-YL)PIPERAZINE-1-CARBOXAMIDE | N-(2-METHOXYPHENYL)-4-(8-PYRIMIDIN-5-YLQUINOLIN-2-YL)PIPERAZINE-1-CARBOXAMIDE | |||
6 | 72152-87-5 | 3-[[2-(Acetyloxy)ethyl][4-[[4-(phenylazo)phenyl]azo]phenyl]amino]propanenitrile | 3-[[2-(Acetyloxy)ethyl][4-[[4-(phenylazo)phenyl]azo]phenyl]amino]propanenitrile | ||
7 | (6-[1-(4-METHOXY-PHENYL)-1H-PYRAZOL-4-YL]-PYRIDIN-3-YL)-(4-PYRIDIN-2-YL-PIPERAZIN-1-YL)-METHANONE | (6-[1-(4-METHOXY-PHENYL)-1H-PYRAZOL-4-YL]-PYRIDIN-3-YL)-(4-PYRIDIN-2-YL-PIPERAZIN-1-YL)-METHANONE | |||
8 | 936563-92-7 | 2-Propen-1-one, 1-[4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]-1-piperidinyl]- | PCI-31433 Ibrutinib Impurity 01 Ibrutinib iMpurity WZYG 1-(1-ACRYLOYLPIPERIDIN-4-YL)-3-(4-PHENOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE 1-[4-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-Propen-1-one 1-(4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one 2-Propen-1-one, 1-[4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]-1-piperidinyl]- 1-(4-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (Ibrutinib Impurity) | ||
9 | 936563-96-1 | 1-((3r)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-2-propen-1-one | PCI32765 PCI-32765 Ibrutinib IBRUTINIB PCI-32765 (Ibrutinib) IBRUTINIB (PCI-32765) According to Lu imatinib 1-{3-[4-Amino-3-(4-phenoxy-phenyl)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidin-1-yl}-propenone (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo-[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2- 1-((3r)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-2-propen-1-one 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one 2-Propen-1-one, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]- |
ID | CAS | Product Name | Suppliers | Descriptions |
---|